These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2837340)

  • 1. Effects of choline and inositol on 3H-dihydroalprenolol and 125I-iodocyanopindolol bindings to beta-adrenergic receptors of the guinea pig cerebral cortical membranes.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):360-6. PubMed ID: 2837340
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
    Kawai Y; Graham SM; Yoshioka H; Arinze IJ
    Biochem Pharmacol; 1986 Dec; 35(24):4387-93. PubMed ID: 3024648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.
    Sandnes D; Westergren T; Sand TE; Sager G; Refsnes M; Christoffersen T; Jacobsen S
    Acta Pharmacol Toxicol (Copenh); 1984 Oct; 55(4):287-96. PubMed ID: 6150600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
    Neve KA; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1986 Jul; 238(1):46-53. PubMed ID: 3014123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of 125I-iodocyanopindolol to beta-adrenergic receptors: biphasic Scatchard plots. II. Effects of selective antagonists.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3425-32. PubMed ID: 2892590
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure to find beta-adrenergic receptor binding in guinea pig cerebral cortex with [3H]dihydroalprenolol.
    Clark C; Hoyler E; Davis JN
    Brain Res; 1977 May; 127(2):313-6. PubMed ID: 193615
    [No Abstract]   [Full Text] [Related]  

  • 8. Biphasic binding of 125I-iodocyanopindolol to beta-adrenergic receptors in rat cerebral cortical membranes. I. Assessment by the use of agonists.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2966-72. PubMed ID: 2890440
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
    Meier KE; Ruoho AE
    Biochim Biophys Acta; 1984 Jul; 804(3):331-40. PubMed ID: 6146352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
    Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
    Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid-induced binding of [125I]-iodocyanopindolol to non-beta-adrenoceptor sites in guinea-pig trachea.
    Rigby PJ; Passarelli MC; Self GJ; Preuss JM; Goldie RG
    Biochem Pharmacol; 1988 Apr; 37(7):1421-4. PubMed ID: 2833281
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased beta-adrenergic responses in the female rat brain are eliminated by ovariectomy: correlation of [3H]dihydroalprenolol binding and catecholamine stimulated cyclic AMP levels.
    Wagner HR; Davies JN
    Brain Res; 1980 Nov; 201(1):235-9. PubMed ID: 6251952
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 15. (-)-[3H]Dihydroalprenolol binding in subcellular fractions of rat cortex following noradrenergic denervation.
    Giron LT; Davis JN
    Brain Res; 1981 Oct; 223(1):223-8. PubMed ID: 6269702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bromoacetylalprenololmentane on rat atrial tension development and beta-adrenoreceptors.
    Posner P; Peterson CV; Pitha J; Baker SP
    Eur J Pharmacol; 1984 May; 100(3-4):373-6. PubMed ID: 6329781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of beta-adrenoceptors in bovine intracerebral microvessels and cerebral grey matter by [3H]dihydroalprenolol binding.
    Culvenor AJ; Jarrott B
    Neuroscience; 1981; 6(8):1643-8. PubMed ID: 6267511
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
    Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic binding is increased by melatonin and alpha-adrenergic compounds.
    Sweat FW; Gower BA; Berger PG; Negus NC
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1196-202. PubMed ID: 2875716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.